Tsuboi Ichiro, Araki Motoo, Fujiwara Hiroyasu, Iguchi Toshihiro, Hiraki Takao, Arichi Naoko, Kawamura Kasumi, Maruyama Yuki, Mitsui Yosuke, Sadahira Takuya, Kubota Risa, Nishimura Shingo, Sako Tomoko, Takamoto Atsushi, Wada Koichiro, Kobayashi Yasuyuki, Watanabe Toyohiko, Yanai Hiroyuki, Kitagawa Masashi, Tanabe Katsuyuki, Sugiyama Hitoshi, Wada Jun, Shiina Hiroaki, Kanazawa Susumu, Nasu Yasutomo
Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.
Acta Med Okayama. 2019 Jun;73(3):269-272. doi: 10.18926/AMO/56871.
Nephron-sparing treatment should be offered whenever possible to avoid dialysis in allograph cases. Cryoablation is a new treatment option for treating small-sized renal cell cancer (RCCs). We report a case of RCC arising in a kidney allograft treated by cryoablation. To our knowledge, this is the first case in Asia of RCC in a renal allograft treated using cryoablation. Contrast-enhanced CT-guided percutaneous renal needle biopsy and cryoablation were used to identify the RCC, which could not be identified by other techniques. The postoperative course was uneventful. Contrast-enhanced CT also showed no recurrence or metastases at the 6-month follow-up.
对于同种异体移植病例,应尽可能采用保留肾单位的治疗方法以避免透析。冷冻消融是治疗小尺寸肾细胞癌(RCC)的一种新的治疗选择。我们报告了一例通过冷冻消融治疗的同种异体移植肾中发生的肾细胞癌病例。据我们所知,这是亚洲首例使用冷冻消融治疗的同种异体移植肾中的肾细胞癌病例。采用对比增强CT引导下经皮肾穿刺活检及冷冻消融来识别肾细胞癌,而其他技术无法识别该肾细胞癌。术后过程顺利。对比增强CT在6个月随访时也未显示复发或转移。